These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 25495659

  • 1. Heparin induces an accumulation of atherogenic lipoproteins during hemodialysis in normolipidemic end-stage renal disease patients.
    Barbagallo CM, Noto D, Cefalù AB, Ganci A, Giammarresi C, Panno D, Cusumano G, Greco M, Di Gaudio F, Averna MR.
    Hemodial Int; 2015 Jul; 19(3):360-7. PubMed ID: 25495659
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Lipid Metabolism in Patients with End-Stage Renal Disease: A Five Year Follow-up Study.
    Dusejovska M, Stankova B, Vecka M, Rychlíkova J, Mokrejsova M, Rychlík I, Zak A.
    Curr Vasc Pharmacol; 2018 Jul; 16(3):298-305. PubMed ID: 28554308
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease.
    Vaziri ND, Navab K, Gollapudi P, Moradi H, Pahl MV, Barton CH, Fogelman AM, Navab M.
    J Natl Med Assoc; 2011 Jun; 103(6):524-33. PubMed ID: 21830637
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease.
    Barbagallo CM, Rizzo M, Noto D, Frasheri A, Pernice V, Rubino A, Pieri D, Pinto V, Cefalù AB, Giordano C, Notarbartolo A, Averna MR.
    Metabolism; 2006 May; 55(5):662-8. PubMed ID: 16631444
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Protective Role of Adiponectin for Lipoproteins in End-Stage Renal Disease Patients: Relationship with Diabetes and Body Mass Index.
    Coimbra S, Reis F, Nunes S, Viana S, Valente MJ, Rocha S, Catarino C, Rocha-Pereira P, Bronze-da-Rocha E, Sameiro-Faria M, Oliveira JG, Madureira J, Fernandes JC, Miranda V, Belo L, Santos-Silva A.
    Oxid Med Cell Longev; 2019 May; 2019():3021785. PubMed ID: 30911344
    [Abstract] [Full Text] [Related]

  • 17. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.
    Lee DM, Knight-Gibson C, Samuelsson O, Attman PO, Wang CS, Alaupovic P.
    Kidney Int; 2002 Jan; 61(1):209-18. PubMed ID: 11786103
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
    Srisawasdi P, Vanavanan S, Rochanawutanon M, Pornsuriyasak P, Tantrakul V, Kruthkul K, Kotani K.
    Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.